Cargando…
Role of miR-326 in neonatal hypoxic-ischemic brain damage pathogenesis through targeting of the δ-opioid receptor
Hypoxic-ischemic brain damage (HIBD) is a relatively common malignant complication that occurs in newborn infants, but promising therapies remain limited. In this study, we focused on the role of miR-326 and its target gene δ-opioid receptor (DOR) in the pathogenesis of neonatal HIBD. The expression...
Autores principales: | Wang, Xuan, Zhou, Han, Cheng, Rui, Zhou, Xiaoguang, Hou, Xuewen, Chen, Jun, Qiu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7104519/ https://www.ncbi.nlm.nih.gov/pubmed/32228617 http://dx.doi.org/10.1186/s13041-020-00579-4 |
Ejemplares similares
-
Peptidome analysis of cerebrospinal fluid in neonates with hypoxic-ischemic brain damage
por: Hou, Xuewen, et al.
Publicado: (2020) -
MiR210 in neonatal hypoxic-ischemic encephalopathy
por: Ma, Qingyi, et al.
Publicado: (2017) -
Neuroprotective Mechanism of Icariin on Hypoxic Ischemic Brain Damage in Neonatal Mice
por: Wang, Mengxia, et al.
Publicado: (2022) -
Gallic acid inhibits neuroinflammation and reduces neonatal hypoxic-ischemic brain damages
por: Dong, Xiangjun, et al.
Publicado: (2022) -
MiR-326: Promising Biomarker for Cancer
por: Pan, Yao-Jie, et al.
Publicado: (2019)